Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

NCRI 2017 | Improving pathways for the genetic testing of breast and ovarian cancer

Due to advancements in genetic testing, women who have breast and/or ovarian cancer, or who are at high-risk of developing these cancers, are easier to identify. Genetic testing can also lead to the identification of any relatives who have mutations in the genes responsible for the development of breast and/or ovarian cancer. In this interview, Nazneen Rahman, CBE, FMedSci, of the Institute of Cancer Research, London, UK, discusses plans to make genetic testing for breast and ovarian cancer more accessible in clinics. This interview was held at the 2017 National Cancer Research Institute (NCRI) Conference, held in Liverpool, UK.